Back to Trades
Sell4
Denali Therapeutics Inc.
DNLI
Total Value
$580.8K
Net $580.8K sold
Sales
$580.8K
1 transaction
Company Information
- Company Name
- Denali Therapeutics Inc.
- Ticker Symbol
- DNLI
- CIK
- 0001714899
Insider Information
- Name
- Watts Ryan J.
- Role
- President and CEO, Director
- Location
- SOUTH SAN FRANCISCO, CA
DirectorOfficer
Filing Details
- Filing Date
- Jan 8, 2026
- Transaction Date
- Jan 6, 2026
- Accession Number
- 0001724310-26-000004
- Form Type
- 4
- Net Trading Amount
- -$580.8K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jan 6, 2026 | Common Stock | 35,198 | $16.50 | Sale | $580.8K |
Footnotes
- (F1)Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested RSUs.
- (F2)Includes 184,915 Unvested RSUs.
- (F3)The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.